CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency

CD32; HIV cure; HIV latency; HIV persistence; HIV reservoir; CD32 antigen; Article; CD4+ T lymphocyte; DNA transcription; Human immunodeficiency virus infection

Abstract :

[en] The HIV latent reservoir forms the major hurdle to an HIV cure. The discovery of CD32 as marker of this reservoir has aroused much interest, but subsequent reports have challenged this finding. Here, we observe a positive correlation between the percentages of CD32+ cells among CD4+ T cells of aviremic cART-treated, HIV-infected individuals and their HIV DNA loads in peripheral blood. Moreover, optimization of the CD32+CD4+ T cell purification protocol reveals prominent enrichment for HIV DNA (mean, 292-fold) in these cells. However, no enrichment for HIV RNA is observed in CD32+CD4+ cells, yielding significantly reduced HIV RNA/DNA ratios. Furthermore, HIV proviruses in CD32+CD4+ cells can be reactivated ex vivo to produce virus, strongly suggesting that these cells support HIV transcriptional latency. Our results underscore the importance of isolating pure, bona fide CD32+CD4+ T cells for future studies and indicate that CD32 remains a promising candidate marker of the HIV reservoir. © 2020 The Author(s)CD32a was recently proposed to mark the HIV reservoir, but this finding was subsequently challenged. By using a sequential cell-sorting protocol to purify bona fide CD32+CD4+ cells, Darcis et al. demonstrate HIV DNA enrichment and ex vivo reactivation-mediated virus production in these cells, reinforcing CD32 as an HIV reservoir marker. © 2020 The Author(s)

Disciplines :

Immunology & infectious disease

Author, co-author :

Darcis, Gilles ; Université de Liège - ULiège > I3-Cellular and Molecular Immunology

Kootstra, Neeltje A.; Laboratory of Viral Immune Pathogenesis, Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Hooibrink, Berend; Department of Cell Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

van Montfort, Thijs; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Maurer, Irma; Laboratory of Viral Immune Pathogenesis, Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Groen, Kevin; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Jurriaans, Suzanne; Laboratory of Clinical Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Bakker, Margreet; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

van Lint, Carine; Service of Molecular Virology, Département de Biologie Moléculaire (DBM), Université Libre de Bruxelles (ULB), Gosselies, Belgium

Berkhout, Ben; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Pasternak, Alexander O.; Laboratory of Experimental Virology, Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands

Language :

English

Title :

CD32+CD4+ T Cells Are Highly Enriched for HIV DNA and Can Support Transcriptional Latency

Publication date :

2020

Journal title :

Cell Reports

eISSN :

2211-1247

Publisher :

Elsevier B.V.

Volume :

Issue :

Pages :

2284-2296.e3

Peer reviewed :

Peer Reviewed verified by ORBi

Funders :

Fonds Léon Fredericq
NIH - National Institutes of Health
NIAID - National Institute of Allergy and Infectious Diseases
FRB - Fondation Roi Baudouin
Rotary International

Available on ORBi :

since 13 May 2020

Statistics

Number of views

113 (14 by ULiège)

Number of downloads

70 (11 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Abdel-Mohsen, M., Kuri-Cervantes, L., Grau-Exposito, J., Spivak, A.M., Nell, R.A., Tomescu, C., Vadrevu, S.K., Giron, L.B., Serra-Peinado, C., Genescà, M., et al. CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci. Transl. Med., 10, 2018, eaar6759.
Avettand-Fènoël, V., Hocqueloux, L., Ghosn, J., Cheret, A., Frange, P., Melard, A., Viard, J.P., Rouzioux, C., Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications. Clin. Microbiol. Rev. 29 (2016), 859–880.
Badia, R., Ballana, E., Castellví, M., García-Vidal, E., Pujantell, M., Clotet, B., Prado, J.G., Puig, J., Martínez, M.A., Riveira-Muñoz, E., Esté, J.A., CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat. Commun., 9, 2018, 2739.
Banga, R., Procopio, F.A., Noto, A., Pollakis, G., Cavassini, M., Ohmiti, K., Corpataux, J.M., de Leval, L., Pantaleo, G., Perreau, M., PD-1(+) and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals. Nat. Med. 22 (2016), 754–761.
Banga, R., Procopio, F.A., Ruggiero, A., Noto, A., Ohmiti, K., Cavassini, M., Corpataux, J.M., Paxton, W.A., Pollakis, G., Perreau, M., Blood CXCR3+ CD4 T Cells Are Enriched in Inducible Replication Competent HIV in Aviremic Antiretroviral Therapy-Treated Individuals. Front. Immunol., 9, 2018, 144.
Barton, K., Hiener, B., Winckelmann, A., Rasmussen, T.A., Shao, W., Byth, K., Lanfear, R., Solomon, A., McMahon, J., Harrington, S., et al. Broad activation of latent HIV-1 in vivo. Nat. Commun., 7, 2016, 12731.
Bertagnolli, L.N., White, J.A., Simonetti, F.R., Beg, S.A., Lai, J., Tomescu, C., Murray, A.J., Antar, A.A.R., Zhang, H., Margolick, J.B., et al. The role of CD32 during HIV-1 infection. Nature 561 (2018), E17–E19.
Boom, R., Sol, C.J., Salimans, M.M., Jansen, C.L., Wertheim-van Dillen, P.M., van der Noordaa, J., Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990), 495–503.
Bruner, K.M., Murray, A.J., Pollack, R.A., Soliman, M.G., Laskey, S.B., Capoferri, A.A., Lai, J., Strain, M.C., Lada, S.M., Hoh, R., et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat. Med. 22 (2016), 1043–1049.
Bruner, K.M., Wang, Z., Simonetti, F.R., Bender, A.M., Kwon, K.J., Sengupta, S., Fray, E.J., Beg, S.A., Antar, A.A.R., Jenike, K.M., et al. A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566 (2019), 120–125.
Buzon, M.J., Sun, H., Li, C., Shaw, A., Seiss, K., Ouyang, Z., Martin-Gayo, E., Leng, J., Henrich, T.J., Li, J.Z., et al. HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat. Med. 20 (2014), 139–142.
Chavez, L., Calvanese, V., Verdin, E., HIV Latency Is Established Directly and Early in Both Resting and Activated Primary CD4 T Cells. PLoS Pathog., 11, 2015, e1004955.
Chomont, N., El-Far, M., Ancuta, P., Trautmann, L., Procopio, F.A., Yassine-Diab, B., Boucher, G., Boulassel, M.R., Ghattas, G., Brenchley, J.M., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15 (2009), 893–900.
Chun, T.W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., Siliciano, R.F., In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat. Med. 1 (1995), 1284–1290.
Chun, T.W., Carruth, L., Finzi, D., Shen, X., DiGiuseppe, J.A., Taylor, H., Hermankova, M., Chadwick, K., Margolick, J., Quinn, T.C., et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387 (1997), 183–188.
Chun, T.W., Davey, R.T. Jr., Ostrowski, M., Shawn Justement, J., Engel, D., Mullins, J.I., Fauci, A.S., Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med. 6 (2000), 757–761.
Chun, T.W., Nickle, D.C., Justement, J.S., Large, D., Semerjian, A., Curlin, M.E., O'Shea, M.A., Hallahan, C.W., Daucher, M., Ward, D.J., et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Invest. 115 (2005), 3250–3255.
Dahabieh, M.S., Battivelli, E., Verdin, E., Understanding HIV latency: the road to an HIV cure. Annu. Rev. Med. 66 (2015), 407–421.
Darcis, G., Van Driessche, B., Van Lint, C., HIV Latency: Should We Shock or Lock?. Trends Immunol. 38 (2017), 217–228.
Darcis, G., Das, A.T., Berkhout, B., Tackling HIV Persistence: Pharmacological versus CRISPR-Based Shock Strategies. Viruses, 10, 2018, E157.
Darcis, G., Berkhout, B., Pasternak, A.O., The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like. Front. Immunol., 10, 2019, 2251.
Davey, R.T. Jr., Bhat, N., Yoder, C., Chun, T.W., Metcalf, J.A., Dewar, R., Natarajan, V., Lempicki, R.A., Adelsberger, J.W., Miller, K.D., et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. USA 96 (1999), 15109–15114.
Deeks, S.G., Lewin, S.R., Ross, A.L., Ananworanich, J., Benkirane, M., Cannon, P., Chomont, N., Douek, D., Lifson, J.D., Lo, Y.R., et al., International AIDS Society Towards a Cure Working Group. International AIDS Society global scientific strategy: towards an HIV cure 2016. Nat. Med. 22 (2016), 839–850.
Descours, B., Petitjean, G., López-Zaragoza, J.L., Bruel, T., Raffel, R., Psomas, C., Reynes, J., Lacabaratz, C., Levy, Y., Schwartz, O., et al. CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature 543 (2017), 564–567.
Douek, D.C., Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev. 5 (2003), 172–177.
Estes, J.D., Kityo, C., Ssali, F., Swainson, L., Makamdop, K.N., Del Prete, G.Q., Deeks, S.G., Luciw, P.A., Chipman, J.G., Beilman, G.J., et al. Defining total-body AIDS-virus burden with implications for curative strategies. Nat. Med. 23 (2017), 1271–1276.
Finzi, D., Hermankova, M., Pierson, T., Carruth, L.M., Buck, C., Chaisson, R.E., Quinn, T.C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278 (1997), 1295–1300.
Finzi, D., Blankson, J., Siliciano, J.D., Margolick, J.B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5 (1999), 512–517.
Fletcher, C.V., Staskus, K., Wietgrefe, S.W., Rothenberger, M., Reilly, C., Chipman, J.G., Beilman, G.J., Khoruts, A., Thorkelson, A., Schmidt, T.E., et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc. Natl. Acad. Sci. USA 111 (2014), 2307–2312.
Fromentin, R., Bakeman, W., Lawani, M.B., Khoury, G., Hartogensis, W., DaFonseca, S., Killian, M., Epling, L., Hoh, R., Sinclair, E., et al. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART. PLoS Pathog., 12, 2016, e1005761.
Gattinoni, L., Lugli, E., Ji, Y., Pos, Z., Paulos, C.M., Quigley, M.F., Almeida, J.R., Gostick, E., Yu, Z., Carpenito, C., et al. A human memory T cell subset with stem cell-like properties. Nat. Med. 17 (2011), 1290–1297.
Grau-Expósito, J., Serra-Peinado, C., Miguel, L., Navarro, J., Curran, A., Burgos, J., Ocaña, I., Ribera, E., Torrella, A., Planas, B., et al. A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4+ T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients. MBio, 8, 2017, e00876-17.
Hatano, H., Jain, V., Hunt, P.W., Lee, T.H., Sinclair, E., Do, T.D., Hoh, R., Martin, J.N., McCune, J.M., Hecht, F., et al. Cell-based measures of viral persistence are associated with immune activation and programmed cell death protein 1 (PD-1)-expressing CD4+ T cells. J. Infect. Dis. 208 (2013), 50–56.
Hiener, B., Horsburgh, B.A., Eden, J.S., Barton, K., Schlub, T.E., Lee, E., von Stockenstrom, S., Odevall, L., Milush, J.M., Liegler, T., et al. Identification of Genetically Intact HIV-1 Proviruses in Specific CD4+ T Cells from Effectively Treated Participants. Cell Rep. 21 (2017), 813–822.
Ho, Y.C., Shan, L., Hosmane, N.N., Wang, J., Laskey, S.B., Rosenbloom, D.I., Lai, J., Blankson, J.N., Siliciano, J.D., Siliciano, R.F., Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155 (2013), 540–551.
Hogan, L.E., Vasquez, J., Hobbs, K.S., Hanhauser, E., Aguilar-Rodriguez, B., Hussien, R., Thanh, C., Gibson, E.A., Carvidi, A.B., Smith, L.C.B., et al. Increased HIV-1 transcriptional activity and infectious burden in peripheral blood and gut-associated CD4+ T cells expressing CD30. PLoS Pathog., 14, 2018, e1006856.
Hogarth, P.M., Pietersz, G.A., Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat. Rev. Drug Discov. 11 (2012), 311–331.
Holgado, M.P., Sananez, I., Raiden, S., Geffner, J.R., Arruvito, L., CD32 Ligation Promotes the Activation of CD4+ T Cells. Front. Immunol., 9, 2018, 2814.
Iglesias-Ussel, M., Vandergeeten, C., Marchionni, L., Chomont, N., Romerio, F., High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. J. Virol. 87 (2013), 9148–9158.
Imamichi, H., Dewar, R.L., Adelsberger, J.W., Rehm, C.A., O'Doherty, U., Paxinos, E.E., Fauci, A.S., Lane, H.C., Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy. Proc. Natl. Acad. Sci. USA 113 (2016), 8783–8788.
Kaiser, P., Joos, B., Niederöst, B., Weber, R., Günthard, H.F., Fischer, M., Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes. J. Virol. 81 (2007), 9693–9706.
Khoury, G., Anderson, J.L., Fromentin, R., Hartogenesis, W., Smith, M.Z., Bacchetti, P., Hecht, F.M., Chomont, N., Cameron, P.U., Deeks, S.G., Lewin, S.R., Persistence of integrated HIV DNA in CXCR3 + CCR6 + memory CD4+ T cells in HIV-infected individuals on antiretroviral therapy. AIDS 30 (2016), 1511–1520.
Lee, E., Bacchetti, P., Milush, J., Shao, W., Boritz, E., Douek, D., Fromentin, R., Liegler, T., Hoh, R., Deeks, S.G., et al. Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy. Front. Microbiol., 10, 2019, 2214.
Lorenzo-Redondo, R., Fryer, H.R., Bedford, T., Kim, E.Y., Archer, J., Pond, S.L.K., Chung, Y.S., Penugonda, S., Chipman, J., Fletcher, C.V., et al. Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530 (2016), 51–56.
Malnati, M.S., Scarlatti, G., Gatto, F., Salvatori, F., Cassina, G., Rutigliano, T., Volpi, R., Lusso, P., A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat. Protoc. 3 (2008), 1240–1248.
Martin, G.E., Pace, M., Thornhill, J.P., Phetsouphanh, C., Meyerowitz, J., Gossez, M., Brown, H., Olejniczak, N., Lwanga, J., Ramjee, G., et al. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA. Front. Immunol., 9, 2018, 928.
Murray, J.M., Zaunders, J.J., McBride, K.L., Xu, Y., Bailey, M., Suzuki, K., Cooper, D.A., Emery, S., Kelleher, A.D., Koelsch, K.K., PINT Study Team. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy. J. Virol. 88 (2014), 3516–3526.
Noto, A., Procopio, F.A., Banga, R., Suffiotti, M., Corpataux, J.M., Cavassini, M., Riva, A., Fenwick, C., Gottardo, R., Perreau, M., Pantaleo, G., CD32+ and PD-1+ Lymph Node CD4 T Cells Support Persistent HIV-1 Transcription in Treated Aviremic Individuals. J. Virol. 92 (2018), e00901–e00918.
Osuna, C.E., Lim, S.Y., Kublin, J.L., Apps, R., Chen, E., Mota, T.M., Huang, S.H., Ren, Y., Bachtel, N.D., Tsibris, A.M., et al. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature 561 (2018), E20–E28.
Pasternak, A.O., Berkhout, B., HIV Reservoir: Finding the Right Needles in a Needlestack. Cell Host Microbe 20 (2016), 280–282.
Pasternak, A.O., Berkhout, B., What do we measure when we measure cell-associated HIV RNA. Retrovirology, 15, 2018, 13.
Pasternak, A.O., Adema, K.W., Bakker, M., Jurriaans, S., Berkhout, B., Cornelissen, M., Lukashov, V.V., Highly sensitive methods based on seminested real-time reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 unspliced and multiply spliced RNA and proviral DNA. J. Clin. Microbiol. 46 (2008), 2206–2211.
Pasternak, A.O., Jurriaans, S., Bakker, M., Prins, J.M., Berkhout, B., Lukashov, V.V., Cellular levels of HIV unspliced RNA from patients on combination antiretroviral therapy with undetectable plasma viremia predict the therapy outcome. PLoS ONE, 4, 2009, e8490.
Pasternak, A.O., Lukashov, V.V., Berkhout, B., Cell-associated HIV RNA: a dynamic biomarker of viral persistence. Retrovirology, 10, 2013, 41.
Pérez, L., Anderson, J., Chipman, J., Thorkelson, A., Chun, T.W., Moir, S., Haase, A.T., Douek, D.C., Schacker, T.W., Boritz, E.A., Conflicting evidence for HIV enrichment in CD32+ CD4 T cells. Nature 561 (2018), E9–E16.
Pillai, S.K., Deeks, S.G., Signature of the Sleeper Cell: A Biomarker of HIV Latency Revealed. Trends Immunol. 38 (2017), 457–458.
Pinzone, M.R., VanBelzen, D.J., Weissman, S., Bertuccio, M.P., Cannon, L., Venanzi-Rullo, E., Migueles, S., Jones, R.B., Mota, T., Joseph, S.B., et al. Longitudinal HIV sequencing reveals reservoir expression leading to decay which is obscured by clonal expansion. Nat. Commun., 10, 2019, 728.
Pollack, R.A., Jones, R.B., Pertea, M., Bruner, K.M., Martin, A.R., Thomas, A.S., Capoferri, A.A., Beg, S.A., Huang, S.H., Karandish, S., et al. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host Microbe 21 (2017), 494–506.e4.
Rothenberger, M., Nganou-Makamdop, K., Kityo, C., Ssali, F., Chipman, J.G., Beilman, G.J., Hoskuldsson, T., Anderson, J., Jasurda, J., Schmidt, T.E., et al. Impact of Integrase Inhibition compared with nonnucleoside inhibition on HIV reservoirs in Lymphoid Tissues. J. Acquir. Immune Defic. Syndr. 81 (2019), 355–360.
Sharaf, R., Lee, G.Q., Sun, X., Etemad, B., Aboukhater, L.M., Hu, Z., Brumme, Z.L., Aga, E., Bosch, R.J., Wen, Y., et al. HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J. Clin. Invest. 128 (2018), 4074–4085.
Siliciano, J.D., Kajdas, J., Finzi, D., Quinn, T.C., Chadwick, K., Margolick, J.B., Kovacs, C., Gange, S.J., Siliciano, R.F., Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9 (2003), 727–728.
Thornhill, J.P., Pace, M., Martin, G.E., Hoare, J., Peake, S., Herrera, C., Phetsouphanh, C., Meyerowitz, J., Hopkins, E., Brown, H., et al., CHERUB investigators. CD32 expressing doublets in HIV-infected gut-associated lymphoid tissue are associated with a T follicular helper cell phenotype. Mucosal Immunol. 12 (2019), 1212–1219.
van der Sluis, R.M., van Montfort, T., Pollakis, G., Sanders, R.W., Speijer, D., Berkhout, B., Jeeninga, R.E., Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes. PLoS Pathog., 9, 2013, e1003259.
van der Sluis, R.M., van Capel, T.M., Speijer, D., Sanders, R.W., Berkhout, B., de Jong, E.C., Jeeninga, R.E., van Montfort, T., Dendritic cell type-specific HIV-1 activation in effector T cells: implications for latent HIV-1 reservoir establishment. AIDS 29 (2015), 1003–1014.
van Montfort, T., van der Sluis, R., Darcis, G., Beaty, D., Groen, K., Pasternak, A.O., Pollakis, G., Vink, M., Westerhout, E.M., Hamdi, M., et al. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway. EBioMedicine 42 (2019), 97–108.
Vásquez, J.J., Aguilar-Rodriguez, B.L., Rodriguez, L., Hogan, L.E., Somsouk, M., McCune, J.M., Deeks, S.G., Laszik, Z.G., Hunt, P.W., Henrich, T.J., CD32-RNA Co-localizes with HIV-RNA in CD3+ Cells Found within Gut Tissues from Viremic and ART-Suppressed Individuals. Pathog. Immun. 4 (2019), 147–160.
Wiegand, A., Spindler, J., Hong, F.F., Shao, W., Cyktor, J.C., Cillo, A.R., Halvas, E.K., Coffin, J.M., Mellors, J.W., Kearney, M.F., Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART. Proc. Natl. Acad. Sci. USA 114 (2017), E3659–E3668.
Wightman, F., Solomon, A., Khoury, G., Green, J.A., Gray, L., Gorry, P.R., Ho, Y.S., Saksena, N.K., Hoy, J., Crowe, S.M., et al. Both CD31(+) and CD31− naive CD4(+) T cells are persistent HIV type 1-infected reservoirs in individuals receiving antiretroviral therapy. J. Infect. Dis. 202 (2010), 1738–1748.
Williams, J.P., Hurst, J., Stöhr, W., Robinson, N., Brown, H., Fisher, M., Kinloch, S., Cooper, D., Schechter, M., Tambussi, G., et al., SPARTACTrial Investigators. HIV-1 DNA predicts disease progression and post-treatment virological control. eLife, 3, 2014, e03821.
Winckelmann, A., Barton, K., Hiener, B., Schlub, T.E., Shao, W., Rasmussen, T.A., Østergaard, L., Søgaard, O.S., Tolstrup, M., Palmer, S., Romidepsin-induced HIV-1 viremia during effective antiretroviral therapy contains identical viral sequences with few deleterious mutations. AIDS 31 (2017), 771–779.
Wittner, M., Dunay, G.A., Kummer, S., Bockhorn, M., Hüfner, A., Schmiedel, S., Degen, O., van Lunzen, J., Eberhard, J.M., Schulze Zur Wiesch, J., CD32 Expression of Different Memory T Cell Subpopulations in the Blood and Lymph Nodal Tissue of HIV Patients and Healthy Controls Correlates With Immune Activation. J. Acquir. Immune Defic. Syndr. 77 (2018), 345–349.